Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Kostandinos Sideras

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4698-2105; OpenAlex author ID A5051516231. Sources: OpenAlex.

Their work

Papers
6 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 2 papers

Papers 6

  1. Spatial genomics reveals a high number and specific location of B cells in the pancreatic ductal adenocarcinoma microenvironment of long-term survivors. Co-author DOI 10.3389/fimmu.2022.995715↗
  2. High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2022.827755↗
  3. Type I interferons in pancreatic cancer and development of new therapeutic approaches. First author DOI 10.1016/j.critrevonc.2020.103204↗
  4. Cancer Cell B7-H3 Expression Is More Prevalent in the Pancreato-Biliary Subtype of Ampullary Cancer Than in Pancreatic Cancer. First author DOI 10.3389/fonc.2021.615691↗
  5. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilir… First author DOI 10.1097/sla.0000000000002660↗
  6. Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. Co-author DOI 10.1016/j.ctrv.2013.11.005↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Casper H.J. van Eijck · 6 shared papers, 2014–2022 · strength 0.73
  2. Mohammad Hosein Aziz · 3 shared papers, 2019–2022 · strength 0.35
  3. Dana A. M. Mustafa · 2 shared papers, 2022 · strength 0.27
  4. Mustafa Suker · 2 shared papers, 2019–2022 · strength 0.21
  5. Bas Groot Koerkamp · 2 shared papers, 2019–2022 · strength 0.21
  6. J. Sven D. Mieog · 2 shared papers, 2019–2022 · strength 0.21
  7. Amber Blaauboer · 1 shared paper, 2021 · strength 0.19
  8. Leo J. Hofland · 1 shared paper, 2021 · strength 0.19
  9. Jaap Kwekkeboom · 2 shared papers, 2014–2021 · strength 0.19
  10. Marco J. Bruno · 2 shared papers, 2014–2021 · strength 0.19
  11. Hosein M. Aziz · 1 shared paper, 2022 · strength 0.15
  12. Willem de Koning · 1 shared paper, 2022 · strength 0.15
  13. Yunlei Li · 1 shared paper, 2022 · strength 0.15
  14. Jaime Feliú · 1 shared paper, 2022 · strength 0.15
  15. Emma E. Geerdes · 1 shared paper, 2021 · strength 0.14
  16. Claudia J. Lucassen · 1 shared paper, 2022 · strength 0.13
  17. Jesse V. Groen · 1 shared paper, 2022 · strength 0.13
  18. Jelle C. van Dongen · 1 shared paper, 2022 · strength 0.13
  19. Bert A. Bonsing · 1 shared paper, 2019 · strength 0.08
  20. Maikel Petrus Peppelenbosch · 1 shared paper, 2014 · strength 0.05
  21. Henri Braat · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.